PubMed Health⌕ Search

Biomedical subjects

R F Ebert

Publications and source records attributed to R F Ebert.

23 records · Page 2Linked to original sources

Fibrinogen Baltimore IV: congenital dysfibrinogenemia with delayed fibrin monomer polymerization.

A congenital dysfibrinogenemia, fibrinogen Baltimore IV, has been found in a 56-year-old Caucasian man. Clinical laboratory studies disclosed a slightly prolonged prothrombin time, but were otherwise unremarkable. Release of fibrinopeptides by thrombin occurs normally, as does ligation of the fibrin polymer by Factor XIII. Approximately half of the isolated fibrin monomers polymerize normally, but the remainder polymerize at about 2% of the initial rate. The functional defect is thus limited to a decrease in the rate of fibrin monomer polymerization.

Afibrinogenemia↗

Assay of human fibrinopeptides by high-performance liquid chromatography.

Fibrinopeptides A, AP, and B, desarginine fibrinopeptide B, and a previously unknown peptide corresponding to B beta 3-14 were resolved within 10 min by an HPLC technique using an isocratic solvent system (22% acetonitrile in 0.1% trifluoroacetic acid) and a 0.46 X 10-cm Spherisorb ODS-2 (3-micron) octadecylsilane column. Fibrinopeptides A and AY eluted in the same peptide peak. The method was used to evaluate a carboxypeptidase which converts fibrinopeptide B into its desarginine form. Fifty percent inhibition of this activity occurred at 1.7 mM epsilon-aminocaproic acid (EACA). At saturating substrate concentrations the rates of total fibrinopeptides A and B release were unaffected by 125 mM EACA, a concentration at which the carboxypeptidase activity is completely inhibited.

Amino Acid Sequence↗

Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis.

A congenital hypodysfibrinogenemia, fibrinogen Baltimore II, was found in a young asymptomatic Caucasian female. Prothrombin, partial thromboplastin, and euglobulin lysis times were normal, as were platelet function and coagulation factor assays. Subnormal plasma fibrinogen levels were found using chronometric, rate-independent, and immunologic assay methods. Kinetic analysis of fibrinopeptide release revealed a delay in the thrombin-catalyzed release of fibrinopeptide B from the abnormal protein. Proteolysis of fibrinopeptide A by thrombin or Arvin, fibrin monomer polymerization, and fibrin polymer ligation occurred at normal rates. Catabolism of radiolabeled autologous and homologous fibrinogen was also normal, but the fibrinogen synthetic rate was less than half the normal value. Comparison of the coagulation characteristics of fibrinogen Baltimore II with those of other abnormal fibrinogens indicates that it represents a unique example of hypodysfibrinogenemia.

Adult↗

Isolation and characterization of two adenosine 3',5'-monophosphate-dependent protein kinases from bovine adrenal cortex.

Bovine adrenocortical cytosol contains two cAMP-dependent protein kinases separable by diethylamino-ethyl-cellulose chromatography. The kinases exhibit behavior characteristic of type I and type II enzymes i.e. the enzyme eluting at 80 mM NaCl is activated by NaCl and histone, whereas the enzyme eluting at 140 mM NaCl is not. In addition, a third cAMP-binding protein eluting from DEAE at 120 mM NaCl has been isolated and tentatively identified as type I regulatory subunit. A method is described for the isolation of the catalytic and regulatory subunits of both enzymes from the same starting material using cGMP to dissociate the enzyme subunits and elute the regulatory subunits from N6-aminoethyl-cAMP-Sepharose 4B. The isolated proteins were homogeneous, as judged by sodium dodecyl sulfate-polyacrylamide electrophoresis. Using this technique, molecular weight values of 44,000 for the catalytic subunits, 51,000 for the cAMP-binding protein and type I regulatory subunit, and 56,000 for the type II regulatory subunit were obtained. Molecular weights obtained by sucrose density gradient centrifugation on the cGMP-dissociated holoenzymes were 95,000 and 101,000 for regulatory subunits from type I and II enzymes and 34,000 and 33,000 for their respective catalytic subunits. The apparent Km and Vmax values for catalytic subunits I and II were similar when histone, casein, or ATP was used as substrate. The Vmax for protamine phosphorylation was 3-fold higher with catalytic subunit II. Phosvitin was not a substrate for either subunit. The cAMP-binding protein and regulatory subunit I were able to recombine with, i.e. inhibit, either catalytic subunit. At a molar ratio of 4:1, inhibition was total. The type II regulatory subunit was considerably less effective. Preference for a particular catalytic subunit was not evident in the case of inhibition by either regulatory subunit or the cAMP-binding protein.

Adrenal Cortex↗

Immunotoxin construction with a ribosome-inactivating protein from barley.

The aim of this study was to determine the suitability of a ribosome-inactivating protein (RIP) from barley endosperm for use as an immunotoxin. This barley RIP is identical with the 30-kDa protein first reported by Coleman and Roberts [(1982) Biochim. Biophys. Acta 696, 239] and sequenced by Asano and co-workers [(1986) Carlsberg Res. Commun. 51, 75]. Use of the terms barley toxin I, II, and III is proposed to describe the three isoforms resolved by cation-exchange chromatography. An improved procedure for isolating the protein involving the steps of aqueous extraction, ammonium sulfate precipitation, and cation-exchange HPLC is described. Barley toxin II retained activity after exposure to ca. 40% acetonitrile and 0.1% trifluoroacetic acid or lyophilization. In a comparative study using the rabbit reticulocyte lysate assay, the protein was about 68% and 30% as potent as gelonin and ricin A-chain (RTA), respectively. Introduction of SH groups with 2-iminothiolane resulted in a substantial loss of activity as the number of thiol groups approached four. Therefore, it was necessary to limit thiolation to an average of one to two SH groups per toxin molecule. Anti-transferrin receptor-based immunotoxins constructed with RTA, gelonin, and barley toxin II exhibited comparable cytotoxicity against a human colon tumor cell line. We conclude that the availability of raw material, ease of purification, and stability of barley toxin II to lyophilization and denaturing conditions render it a suitable protein for the construction of immunotoxins.

Antibodies, Monoclonal↗